| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A randomized trial of aspirin to prevent colorectal adenomas.
|
N Engl J Med
|
2003
|
9.18
|
|
2
|
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
|
Lancet Oncol
|
2013
|
6.79
|
|
3
|
High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania.
|
Clin Infect Dis
|
2005
|
4.45
|
|
4
|
Colorectal cancer in patients under close colonoscopic surveillance.
|
Gastroenterology
|
2005
|
4.31
|
|
5
|
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.
|
N Engl J Med
|
2015
|
2.88
|
|
6
|
Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network.
|
Lancet Oncol
|
2006
|
2.32
|
|
7
|
A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors.
|
Ann Surg Oncol
|
2009
|
2.00
|
|
8
|
Cognitive function in breast cancer patients prior to adjuvant treatment.
|
Breast Cancer Res Treat
|
2007
|
1.95
|
|
9
|
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients.
|
Clin Cancer Res
|
2009
|
1.94
|
|
10
|
Analyzing oncology clinical trial data using the Q-TWiST method: clinical importance and sources for health state preference data.
|
Qual Life Res
|
2006
|
1.93
|
|
11
|
Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot.
|
J Clin Oncol
|
2010
|
1.79
|
|
12
|
Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial.
|
J Natl Cancer Inst
|
2003
|
1.79
|
|
13
|
Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.
|
J Natl Cancer Inst
|
2007
|
1.73
|
|
14
|
Effect of calcium supplementation on the risk of large bowel polyps.
|
J Natl Cancer Inst
|
2004
|
1.67
|
|
15
|
Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.
|
J Clin Oncol
|
2010
|
1.51
|
|
16
|
Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer.
|
Breast Cancer Res Treat
|
2010
|
1.48
|
|
17
|
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.46
|
|
18
|
Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed--biologic concordance and women's preferences.
|
Am J Obstet Gynecol
|
2002
|
1.41
|
|
19
|
Cognitive-behavioral management of chemotherapy-related cognitive change.
|
Psychooncology
|
2007
|
1.41
|
|
20
|
Pigmentary characteristics and moles in relation to melanoma risk.
|
Int J Cancer
|
2005
|
1.40
|
|
21
|
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma.
|
Ann Surg Oncol
|
2005
|
1.30
|
|
22
|
A controlled trial of methods for managing pain in primary care patients with or without co-occurring psychosocial problems.
|
Ann Fam Med
|
2006
|
1.25
|
|
23
|
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.
|
Clin Colorectal Cancer
|
2009
|
1.20
|
|
24
|
Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture.
|
BMC Infect Dis
|
2008
|
1.14
|
|
25
|
SunSafe in the Middle School Years: a community-wide intervention to change early-adolescent sun protection.
|
Pediatrics
|
2007
|
1.13
|
|
26
|
A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data.
|
Stat Med
|
2009
|
1.11
|
|
27
|
The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.
|
J Clin Oncol
|
2007
|
1.10
|
|
28
|
Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data.
|
J Clin Oncol
|
2002
|
1.07
|
|
29
|
Expression of "Spot 14" (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker.
|
Breast Cancer Res Treat
|
2006
|
1.05
|
|
30
|
Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation.
|
Epidemiology
|
2008
|
1.05
|
|
31
|
The association of physical activity and body mass index with the risk of large bowel polyps.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.04
|
|
32
|
Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).
|
Cancer Causes Control
|
2006
|
0.95
|
|
33
|
Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yang.
|
Clin Cancer Res
|
2007
|
0.93
|
|
34
|
Factors affecting the detection rate of human papillomavirus.
|
Ann Fam Med
|
2004
|
0.93
|
|
35
|
A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme.
|
J Neurooncol
|
2008
|
0.90
|
|
36
|
Tampon samplings with longer cervicovaginal cell exposures are equivalent to two consecutive swabs for the detection of high-risk human papillomavirus.
|
Sex Transm Dis
|
2002
|
0.88
|
|
37
|
Gastrin, Helicobacter pylori, and colorectal adenomas.
|
Clin Gastroenterol Hepatol
|
2008
|
0.85
|
|
38
|
Impaired cytolytic activity in peripheral blood T cells from renal cell carcinoma patients.
|
Clin Immunol
|
2005
|
0.84
|
|
39
|
Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.83
|
|
40
|
Tumor-related immunity in prostate cancer patients treated with human recombinant granulocyte monocyte-colony stimulating factor (GM-CSF).
|
Prostate
|
2006
|
0.83
|
|
41
|
Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer--authors' reply.
|
Lancet Oncol
|
2013
|
0.81
|
|
42
|
Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.
|
J Infect Dis
|
2006
|
0.81
|
|
43
|
MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.80
|
|
44
|
Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma.
|
Head Neck
|
2009
|
0.79
|
|
45
|
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.
|
Breast Cancer Res Treat
|
2012
|
0.79
|
|
46
|
Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.
|
Support Care Cancer
|
2007
|
0.78
|
|
47
|
Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.78
|
|
48
|
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.
|
Clin Colorectal Cancer
|
2009
|
0.77
|
|
49
|
Maternal androgen and estrogen concentrations are not associated with blood pressure changes in uncomplicated pregnancies.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.77
|
|
50
|
Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinoma.
|
J Urol
|
2004
|
0.76
|
|
51
|
The pharmacokinetics of the bispecific antibody MDX-H210 when combined with interferon gamma-1b in a multiple-dose phase I study in patients with advanced cancer.
|
Cancer Chemother Pharmacol
|
2002
|
0.76
|
|
52
|
Another STEPP in the right direction.
|
J Clin Oncol
|
2008
|
0.75
|
|
53
|
Native MAG-1 antibody almost destroys human breast cancer xenografts.
|
Breast Cancer Res Treat
|
2010
|
0.75
|
|
54
|
Factors associated with atypical moles in New Hampshire, USA.
|
Acta Derm Venereol
|
2007
|
0.75
|